International Journal of Hematology · 2016 · 21 citations · 15 references
MedicineClinical SciencesPharmacologyClinical PharmacologyComorbidityComorbidity AssessmentMedical ComorbiditiesReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsCharlson Comorbidity IndexChronic Myeloid Leukemia TherapyComorbidity IndicesComorbidity ManagementComorbidity PrognosisComorbidity-based Risk ProfilingTyrosine Kinase InhibitionTyrosine Kinase Inhibitor Therapy
15
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text
Medicine, Hematology, Oncology +13
Prognostic discrimination in "good-risk" chronic granulocytic leukemia
JE Sokal, Cox Eb, Michele Baccarani et al. · Blood · 1984 · 1K citations · Full text
Medicine, Hematology, Oncology +13
Prognostic discrimination in "good-risk" chronic granulocytic leukemia
JE Sokal, Cox Eb, Michele Baccarani et al. · Blood · 1984 · 962 citations
Medicine, Hematology, Oncology +13
Milena Sant, Claudia Allemani, Carmen Ţereanu et al. · Blood · 2010 · 958 citations · Full text
Medicine, Hematology, Pathology +16